Have a personal or library account? Click to login
Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients Cover

Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
By: Aleksander Michalski,  Magdalena Goralczyk,  Michal Brzozowski,  Jakub Dworzanski,  Bartlomiej Drop,  Ewa Stepien and  Malgorzata Polz-Dacewicz  
Open Access
|Dec 2023

Metrics

DOI: https://doi.org/10.2478/cipms-2023-0038 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 221 - 226
Submitted on: Jul 6, 2023
|
Accepted on: Nov 15, 2023
|
Published on: Dec 25, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SARS-CoV-2 antibody,
diabetes,
NCP,
RBD,
S2,
vaccination
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Aleksander Michalski, Magdalena Goralczyk, Michal Brzozowski, Jakub Dworzanski, Bartlomiej Drop, Ewa Stepien, Malgorzata Polz-Dacewicz, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 36 (2023): Issue 4 (December 2023)Next article